Lithium addition in treatment-resistant depression

International Clinical Psychopharmacology

Volumn 9, Issue , 1994, Pages 31-36

  De Montigny, C ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Lithium augmentation; Resistant depression; Tricyclic antidepressant

Indexed keywords

LITHIUM; TRICYCLIC ANTIDEPRESSANT AGENT;

CONFERENCE PAPER; DEPRESSION; DRUG COMBINATION; HUMAN; PRIORITY JOURNAL; SEROTONINERGIC NERVE; THERAPY RESISTANCE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; HUMAN; LITHIUM;

EID: 0028243391     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/00004850-199406002-00006     Document Type: Article

References (51)

1. Alvarez E, Udina C, Queralto JM et al. (1984) Factors indicating the favourable response of lithium added to the treatment of resistant depressions. Coll int Neuropsychopharmacol 14 75.
2. Austin LS, Arena GW and Melvin JA (1990) Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients. Journal of Clinical Psychiatry, 51, 344-345.
3. Blier P and de Montigny C (1985) Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS. European Journal of Pharmacology. 133, 66-77.
4. Broderick I and Lynch V (1982) Behavioral and ha chemical changes induced by lithium and L-tryptophan in muricidal rats. Neuropharmacology. 21, 671-679.
5. Cøppen A and Ahou-Saleh MT (1988) Lithium therapy: from clinical trials to practical management. At in Psychiatrica Scandinavica. 78. 754-762.
6. Cournoyer G., de Montigny Quellette J et al. (1984) Lithium addition in tricvclic-resistant unipolar depression: a placebo- controlled study. Coll Ini Ncuropsychophannacol, 14, F-177.
7. de Montigny C and Aghajanian GK (1978) Tricyclic antidepres- sants: long-term treatment increases response of rat torebrain neurons to serotonin. Science. 202, 1303-1306.
8. de Montignv C., Grunberg F, Mayer A and Deschenes JP (1981) Lithium induces rapid relief of depression in tricyclic anti- depressant drug non-responders. British Journal of Psychiatry. 138. 252-256.
9. de Montigny C, Cournoyer G, Monssette R, Langlois R and Caillé G (1983) Lithium carbonate addition in tricyclic anti-deprcssant-rcsistant unipolar depression. Archives of General Psychiatry, 40. 1327-1334.
10. Delgado PL., Price LH, Charney DS and Heninger GR (1988) Efficacy of fluvoxamine in treatment-refractory depression. Journal of Affective Disorders. 15, 55-60.
11. Delisle JD (1986) Rapid switch in a bipolar patient during lithium-tricyclic therapy. American Journal of Psychiatry. 143, 1326-1327.
12. Dinan TG and Barry S (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatrica Scundinuvica, 8, 97-100.
13. Eisen A (1989) Fluoxetine and desipramine: a strategy for augmenting antidepressant response. Pharmacopsychiatry. 22, 272-273.
14. Evans M and Marwiek P (1990) Fluvoxamine and lithium: an unusual interaction. British Journal of Psychiatry, 156, 286.
15. Finch EJL and Katona CLE (1989) Lithium augmentation in the treatment of refractory depression in old age. International Journal of Geriatric Psychiatry, 4, 41-46.
16. Flint A (1992) Lithium augmentation in antidepressant-resistant patients. British Journal of Psychiatry. 160. 710.
17. Fontaine R., Ontiveros A, Elie R and Vezina M (1991) Lithium carbonate augmentation of desipramine and fluoxetine in refractory depression. Biological Psychiatry. 29. 946-948.
18. Garbutt JC, Mayo JP, Gillette GM., Little KY and Mason GA (1986) Lithium potentiation of tricyclic antidepressants following lack of T, potentiation. American Journal of Psychiatry, 143, 1038-1039.
19. Grahame-Smith DG and Green AR (1974) The role of brain 5-hydroxytryptamine in the hyperactivity produced by lithium and monoamine oxidase inhibition. British Journal of Pharmacology, 52. 19-26.
20. Hadley A and Cason MP (1989) Mania resulting from lithium- fluoxetine combination. American Journal of Psychiatry, 146. 1637-1638.
21. Hale AS., Procter AW and Bridges PK (1987) Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies. British Journal of Psychiatry, 151, 213-217.
22. Heninger GR, Charney DS and Slemberg DE (1983) Lithium carbonate augmentation of antidepressant treatment. Archives ofGeneral Psychiatry, 40, 1335-1342.
23. Howland RH (1991) Lithium augmentation of fluoxetine in the treatment of OCD and major depression: a ease report. Canadian Journal of Psychiatry. 36, 154-155.
24. Jolfe RT (1988) T3 and lithium potentiation of tricyclic anti- depressants. American Journal of Psychiatry. 145. 1317-1318.
25. Joyce PR., Hewland HR and Jones AV (1983) Rapid response to lithium in treatment-resistant depression. British Journal of Psychiatry, 142. 204-214.
26. Kantor D, McNevin S, Leiehner P., Harper D and Krenn M (1986) The benefit of lithium carbonate adjunct in refractory depression: fact or fiction? Canadian Journal of Psychiatry. 31, 416-418.
27. Katona CLE, Finch JL, Soni SD and Shrimankar J (1988) Late life depression: undertreated? British Medical Journal, 296, 929-930.
28. Khan MC, Wickham AL and Reed JV (1987) Lithium versus placebo in acute depression: a clinical trial. International Clinical Psychopharmacology. 2. 47-54.
29. Kramlinger KG and Post RM (1989) The addition of lithium to carbamazepine. Archives of General Psychiatry, 46. 794-800.
30. Kushnir SL (1986) Lithium-antidepressant combinations in the treatment of depressed, physically ill geriatric patients. American Journal of Psychiatry. 143, 378-379.
31. Louie AD and Meltzer HY (1984) Lithium potentiation of anti- depressant treatment. Journal of Clinical Psychopharmacology, 4. 316-321.
32. Madakasira S (1986) Low dose potency of lithium in antidepressant augmentation. Psychiatry J University of Ottawa. 11, 107-109.
33. Nierenberg AA (1990) Methodological problems in treatment resistant depression research. Psychophannacological Bulletin, 26, 461-464.
34. Noveske FG. Hahn KR and Flynn RJ (1989) Possible toxicity of combined fluoxetine and lithium. American Journal of Psychiatry. 146. 1515.
35. Pai MA, White AC and Deane AG (1986) Lithium augmentation in the treatment of delusional depression. British Journal of Psychiatry, 148, 736-738.
36. Price LH. Conwell Y and Nelson C (1983) Lithium augmentation of combined neuroleptic-tricyclic in delusional depression. American Journal of Psychiatry, 140, 318-322.
37. Price LH, Charney DS and Heninger GR (1984) Manic symptoms following addition of lithium to antidepressant treatment. Journal of Clinical Psychopharmacology. 4. 361-362.
38. Price LH, Charney DS and Heninger GR (1986) Variability of response to lithium augmentation in refractory depression. American Journal of Psychiatry. 143, 1387-1392.
39. Prudic J and Saekeim HA (1992) Refractory depression and electroconvulsive therapy. In: Treatment Strategies for Refractors Depression (Eds SP Roose and AH Glassman), pp. 109-128. American Psychiatric Press, Washington. DC.
40. Roy A and Pickar D (1985) Lithium potentiation of imipramine in treatment resistant depression. British Journal of Psychiatry, 147. 582-583.
41. Sacristan JA, Iglesias C., Arellano F and Lequerica J (1991) Absence seizures induced by lithium: possible interaction with fluoxetine. American Journal of Psychiatry. 148 146-147.
42. Saiama A A and Shafey M (1989) A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate. American Journal of Psychiatry. 146, 278.
43. Sangdee C and Franz DN (1978) Lithium-induced enhancement of 5-HT transmission at a central synapse. Community Psychopharmacology. 2, 191-198.
44. Schopf J, Bauman P, Lemarchand T and Ray M (1989) Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition: results of placebo-controlled double-blind study. Pharmacopsychiatry, 2, 183-187.
45. Schrader GD and Levien HEM (1985) Response to sequential administration of clomipramine and lithium carbonate in treatment-resistant depression. British Journal of Psychiatry, 147. 573-575.
46. Shapira B, Kindler S and Lerer B (1988) Medication outcome in ECT-resistant depression. Convulsive Therapy, 45, 192-198.
47. Thase ME, Kupfer DJ and Jarrett DB (1989a) Treatment of imi-pramine-resistant recurrent depression: I. An open clinical trial of adjunctive L-triiodothyronine. Journal of Clinical Psychiatry, 50, 385-388.
48. Thase ME, Kupfer DJ, Frank E and Jarrett DB (1989b) Treatment of imipramine-resistant recurrent depression: II. An open clinical trial of lithium augmentation. Journal of Clinical Psychiatry, 50, 413-417.
49. Treiser SL, Cascio CS, O’ Donohue TL and Keilar K (1981) Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science, 213, 1529-1531.
50. Weaver KEC (1983) Lithium for delusional depression. American Journal of Psychiatry, 140, 962-963.
51. Yuvarajan R and Yousuizai NM (1988) Mania induced by lithium augmentation. British Journal of Psychiatry, 153, 828-830.